Profiel
Nicholas Robbins-Cherry is currently the Chief Financial Officer, Director & Vice President at Ixaka Ltd. He previously worked as the Finance Director at CACI Ltd. from 2008 to 2013 and at The Marketing Practice (UK) Ltd. from 2013 to 2014.
In 2019, he briefly served as the Secretary at Biodexa Pharmaceuticals Plc.
Actieve functies van Nicholas Robbins-Cherry
| Bedrijven | Functie | Begin |
|---|---|---|
Ixaka Ltd.
Ixaka Ltd. BiotechnologyHealth Technology Operates as a preclinical-stage immunotherapy biotech company | Financieel Directeur/CFO | 01-10-2021 |
Eerdere bekende functies van Nicholas Robbins-Cherry
| Bedrijven | Functie | Einde |
|---|---|---|
| BIODEXA PHARMACEUTICALS PLC | Financieel Directeur/CFO | 09-09-2019 |
The Marketing Practice (UK) Ltd.
The Marketing Practice (UK) Ltd. Advertising/Marketing ServicesCommercial Services Operates as a B2B marketing agency | Financieel Directeur/CFO | 01-01-2014 |
CACI Ltd.
CACI Ltd. Data Processing ServicesTechnology Services Provides data and technology solutions | Financieel Directeur/CFO | 01-01-2013 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
CACI Ltd.
CACI Ltd. Data Processing ServicesTechnology Services Provides data and technology solutions | Technology Services |
Biodexa Pharmaceuticals Plc
Biodexa Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Designs and manufactures nanomedicines | Health Technology |
The Marketing Practice (UK) Ltd.
The Marketing Practice (UK) Ltd. Advertising/Marketing ServicesCommercial Services Operates as a B2B marketing agency | Commercial Services |
Ixaka Ltd.
Ixaka Ltd. BiotechnologyHealth Technology Operates as a preclinical-stage immunotherapy biotech company | Health Technology |
















